Please use this identifier to cite or link to this item: https://doi.org/10.1186/1477-7819-12-88
Title: Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: A case report and review of the literature
Authors: Ho, C.W.G
Mantoo, S 
Lim, C.H
Wong, C.Y 
Keywords: CD5 antigen
common acute lymphoblastic leukemia antigen
cyclophosphamide
doxorubicin
epidermal growth factor receptor 2
estrogen receptor
prednisolone
progesterone receptor
protein bcl 6
rituximab
vincristine sulfate
acute kidney failure
aged
article
B lymphocyte
bone marrow biopsy
breast carcinoma
cancer chemotherapy
cancer prognosis
case report
CD3+ T lymphocyte
clinical feature
diabetes mellitus
endometrium carcinoma
female
fever
fine needle aspiration biopsy
flu like syndrome
hemodialysis
histology
human
human tissue
hyperlipidemia
hypertension
intraductal carcinoma
karyotyping
large cell lymphoma
mastectomy
mental health
neutropenia
paraneoplastic syndrome
positron emission tomography
primary tumor
protein expression
sepsis
tumor cell destruction
Aged
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Carcinoma, Ductal, Breast
Combined Modality Therapy
Female
Humans
Lymphoma, Large B-Cell, Diffuse
Mastectomy
Neoplasm Invasiveness
Neoplasms, Multiple Primary
Prognosis
Issue Date: 2014
Citation: Ho, C.W.G, Mantoo, S, Lim, C.H, Wong, C.Y (2014). Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: A case report and review of the literature. World Journal of Surgical Oncology 12 (1) : 88. ScholarBank@NUS Repository. https://doi.org/10.1186/1477-7819-12-88
Rights: Attribution 4.0 International
Abstract: Primary breast lymphomas (PBLs) represent less than 1% of all breast malignancies. Intravascular large B-cell lymphoma (ILBCL) is a rare, aggressive form of extranodal lymphoma. Breast involvement has only been described in the literature once previously. ILBCL is characterized by the proliferation of tumour cells within the lumen of small vessels of involved organs, resulting in their eventual occlusion. Clinical features are often vague, diagnosis is difficult and delayed, and prognosis is usually poor. We report the first ever case of synchronous ILBCL and invasive ductal carcinoma (IDC) of the breast in a patient presenting with pyrexia of unknown origin and altered mental status who underwent modified radical mastectomy and subsequent chemotherapy, and review the literature regarding intravascular large B-cell lymphoma, PBLs and synchronous carcinomas and lymphomas of the breast. © 2014 Ho et al.; licensee BioMed Central Ltd.
Source Title: World Journal of Surgical Oncology
URI: https://scholarbank.nus.edu.sg/handle/10635/181505
ISSN: 14777819
DOI: 10.1186/1477-7819-12-88
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_1477-7819-12-88.pdf2.73 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons